Haefeli W E, Schoenenberger R A, Weiss P, Ritz R F
Department of Internal Medicine, University Hospital (Kantonsspital), Basel, Switzerland.
Am J Med. 1993 Feb;94(2):212-5. doi: 10.1016/0002-9343(93)90186-s.
To investigate the concentration-side effect relationship in a patient with severe acyclovir-induced neurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir.
Repeated blood samples were drawn in a patient with severe acyclovir overdose who developed coma and nonoliguric renal failure. The acyclovir levels measured by radioimmunoassay were related to the level of consciousness.
We measured the highest acyclovir serum levels reported so far (229.9 mumol/L = 51.8 mg/L). Impairment of consciousness developed with a remarkable temporal delay of 24 to 48 hours after occurrence of peak serum concentrations and resolved with a comparable delay after reaching the therapeutic range (anticlockwise hysteresis). Six days after discontinuation of the drug, central nervous system symptoms had resolved, and, 4 days later, renal function returned to pretreatment values.
The observation that neurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases. Single drug level measurements may therefore be of little diagnostic value. Since toxicity develops with a remarkable delay, early removal of the drug (by hemodialysis) could possibly prevent central nervous toxicity.
研究一名严重阿昔洛韦诱导神经毒性患者的血药浓度-副作用关系,并总结文献中关于阿昔洛韦引起的中枢神经系统副作用的可用信息。
对一名因阿昔洛韦严重过量导致昏迷和非少尿性肾衰竭的患者多次采集血样。通过放射免疫测定法测得的阿昔洛韦水平与意识水平相关。
我们测得的阿昔洛韦血清水平是迄今为止报道的最高水平(229.9 μmol/L = 51.8 mg/L)。意识障碍在血清浓度峰值出现后24至48小时出现明显的时间延迟,并在达到治疗范围后以类似的延迟得到缓解(逆时针滞后)。停药6天后,中枢神经系统症状得到缓解,4天后,肾功能恢复到治疗前水平。
阿昔洛韦血清浓度峰值后24至48小时出现神经毒性的观察结果可以解释类似病例中报道的阿昔洛韦水平范围广泛的现象。因此,单次血药浓度测量可能诊断价值不大。由于毒性出现有明显延迟,早期清除药物(通过血液透析)可能预防中枢神经毒性。